OBJECTIVES: In the early 1980s, heterogeneous methicillin-resistant Staphylococcus aureus (hetero-MRSA) strains were predominant in the University of Tokyo Hospital. But, in the 1990s, they were completely substituted by homogeneously highly methicillin-resistant S. aureus (homo-MRSA) strains. Since 2000, however, we started observing an increase in MRSA strains with low cefazolin MICs (MRCLSA). This study was performed to understand the phenomenon by characterization of the 'cefazolin-susceptible' MRSA strains. METHODS: A total of 39 MRCLSA strains were collected between July 2000 and June 2002 and compared with 10 homo-MRSA strains isolated during the same period for their antibiograms and genotypes. The strains were also compared with the hetero-MRSA strains isolated in the same hospital in the early 1980s. RESULTS: In contrast to the homogeneous genotype [multilocus sequence type 5 and SCCmec type II.1 (IIa)] and multiresistant nature of the homo-MRSA strains, the MRCLSA strains were composed of various genotypes as revealed by multilocus sequence typing and SCCmec typing and had resistance only to a limited number of antibiotics. Most of the MRCLSA strains were also genetically differentiated from the hetero-MRSA strains of the 1980s. However, population analysis revealed that all of the MRCLSA strains were classified as hetero-MRSA strains. CONCLUSIONS: A new group of hetero-MRSA strains genetically distinct from those dominant in the same hospital in the early 1980s might have emerged in the community and started invading the university hospital. This phenomenon may be caused by the change in the pattern of antibiotic use.
OBJECTIVES: In the early 1980s, heterogeneous methicillin-resistant Staphylococcus aureus (hetero-MRSA) strains were predominant in the University of Tokyo Hospital. But, in the 1990s, they were completely substituted by homogeneously highly methicillin-resistant S. aureus (homo-MRSA) strains. Since 2000, however, we started observing an increase in MRSA strains with low cefazolin MICs (MRCLSA). This study was performed to understand the phenomenon by characterization of the 'cefazolin-susceptible' MRSA strains. METHODS: A total of 39 MRCLSA strains were collected between July 2000 and June 2002 and compared with 10 homo-MRSA strains isolated during the same period for their antibiograms and genotypes. The strains were also compared with the hetero-MRSA strains isolated in the same hospital in the early 1980s. RESULTS: In contrast to the homogeneous genotype [multilocus sequence type 5 and SCCmec type II.1 (IIa)] and multiresistant nature of the homo-MRSA strains, the MRCLSA strains were composed of various genotypes as revealed by multilocus sequence typing and SCCmec typing and had resistance only to a limited number of antibiotics. Most of the MRCLSA strains were also genetically differentiated from the hetero-MRSA strains of the 1980s. However, population analysis revealed that all of the MRCLSA strains were classified as hetero-MRSA strains. CONCLUSIONS: A new group of hetero-MRSA strains genetically distinct from those dominant in the same hospital in the early 1980s might have emerged in the community and started invading the university hospital. This phenomenon may be caused by the change in the pattern of antibiotic use.
Authors: Peter M Kinnevey; Anna C Shore; Grainne I Brennan; Derek J Sullivan; Ralf Ehricht; Stefan Monecke; David C Coleman Journal: Antimicrob Agents Chemother Date: 2014-01-06 Impact factor: 5.191
Authors: Axel Kramer; Hans Wagenvoort; Christina Ahrén; Inka Daniels-Haardt; Philippe Hartemann; Hiro Kobayashi; Andrea Kurcz; Juan Picazo; Gaetano Privitera; Ojan Assadian Journal: GMS Krankenhhyg Interdiszip Date: 2010-02-10
Authors: Liang Chen; José R Mediavilla; Duarte C Oliveira; Barbara M Willey; Herminia de Lencastre; Barry N Kreiswirth Journal: J Clin Microbiol Date: 2009-09-02 Impact factor: 5.948
Authors: Deborah C Holt; Matthew T G Holden; Steven Y C Tong; Santiago Castillo-Ramirez; Louise Clarke; Michael A Quail; Bart J Currie; Julian Parkhill; Stephen D Bentley; Edward J Feil; Philip M Giffard Journal: Genome Biol Evol Date: 2011-08-02 Impact factor: 3.416